Protheragen Unveils Advanced Drug Delivery Systems to Overcome Key Pharma Challenges

Protheragen, a professional service provider based in New York, has announced the roll-out of integrated solutions for advanced drug delivery systems, including hydrogel drug delivery systems, microneedle development, and lyophilized flash release formulations. These technologies aim to tackle common issues in traditional drug administration such as unstable efficacy, low bioavailability, frequent dosing, and limited targeting. The hydrogel drug delivery system leverages hydrogels' biocompatibility and cross-linked polymer network to encapsulate and release therapeutics like small molecules, proteins, and nucleic acids in response to stimuli such as pH, temperature, and enzymes. This enables targeted and sustained release, reducing off-target effects and improving therapeutic outcomes. Protheragen offers multiple hydrogel types for various routes, including injectable, implantable, ocular, transdermal, oral, and nanoparticle-combined hydrogels.

Additionally, Protheragen's microneedle development services focus on transdermal delivery using micron-sized needles to penetrate the skin's stratum corneum, bypassing gastrointestinal metabolism for enhanced bioavailability and localized treatment. Five microneedle types are offered: coated, dissolving, hollow, hydrogel-forming, and solid. The one-stop workflow covers material selection, structural design, formulation optimization, preclinical evaluation, and production scale-up. Complementing these, the lyophilized flash release formulation development service combines freeze-drying and flash-release technologies to optimize drug stability and release performance. Lyophilization converts liquid drugs into solid forms like particles, films, and microspheres, extending shelf life and protecting active ingredients. Controlled release technologies enable rapid or timed release for oral, injectable, and topical applications.

Together, these solutions provide comprehensive services to global pharmaceutical and biomedical clients, with flexible customization to adapt to different drug properties and clinical needs. Protheragen's expertise in hydrogel, microneedle, and lyophilized formulation fields helps research institutions and pharmaceutical enterprises accelerate new drug research and transformation. The company's commitment to solving key pain points in drug delivery aims to improve drug efficacy, patient compliance, and overall pharmaceutical value.